摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S)-2-((2S)-2-((2S)-2-((3S)-3-amino-3-((3aR,6S,6aR)-6-(benzyloxy)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)propanamido)-3-phenylpropanamido)-3-methylbutanamido)propanoic acid

中文名称
——
中文别名
——
英文名称
(2S)-2-((2S)-2-((2S)-2-((3S)-3-amino-3-((3aR,6S,6aR)-6-(benzyloxy)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)propanamido)-3-phenylpropanamido)-3-methylbutanamido)propanoic acid
英文别名
(2S)-2-[[(2S)-2-[[(2S)-2-[[(3S)-3-[(3aR,6S,6aR)-6-benzyloxy-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]-3-amino-propanoyl]amino]-3-phenyl-propanoyl]amino]-3-methyl-butanoyl]amino]propanoic acid;(2S)-2-[[(2S)-2-[[(2S)-2-[[(3S)-3-[(3aR,6S,6aR)-2,2-dimethyl-6-phenylmethoxy-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]-3-aminopropanoyl]amino]-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]propanoic acid
(2S)-2-((2S)-2-((2S)-2-((3S)-3-amino-3-((3aR,6S,6aR)-6-(benzyloxy)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)propanamido)-3-phenylpropanamido)-3-methylbutanamido)propanoic acid化学式
CAS
——
化学式
C34H46N4O9
mdl
——
分子量
654.761
InChiKey
XCOFHBLIDSJNDN-FBZVDWLASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.1
  • 重原子数:
    47
  • 可旋转键数:
    15
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    188
  • 氢给体数:
    5
  • 氢受体数:
    10

反应信息

  • 作为反应物:
    描述:
    (2S)-2-((2S)-2-((2S)-2-((3S)-3-amino-3-((3aR,6S,6aR)-6-(benzyloxy)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)propanamido)-3-phenylpropanamido)-3-methylbutanamido)propanoic acid1-羟基苯并三唑盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下, 以 二氯甲烷 为溶剂, 反应 24.0h, 以91%的产率得到(3S,6S,9S,13S)-13-[(3aR,6S,6aR)-6-benzyloxy-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]-9-benzyl-6-isopropyl-3-methyl-1,4,7,10-tetrazacyclotridecane-2,5,8,11-tetrone
    参考文献:
    名称:
    Linear and cyclic glycopeptide as HIV protease inhibitors
    摘要:
    Novel linear and cyclic glycotetrapeptides were designed, synthesized and tested for inhibition of the wild type C-SA HIV-1 protease enzyme. The incorporation of beta-amino acid sugar to the linear and cyclic peptides resulted in a series of fifteen novel compounds. Linear glycopeptide 4a and cyclic glycopeptide 6a displayed significant activities against the HIV protease enzyme. The experimental results were compared with a computational approach using molecular docking. The sugar hydroxyl group at the C-3 position in linear (4a) as well as cyclic glycopeptide (6a), shows hydrogen bonding interaction with the enzymatic Asp25/Asp25' residues in docking studies. (C) 2012 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2012.11.018
  • 作为产物:
    描述:
    Fmoc-L-缬氨酸Fmoc-L-丙氨酸 、 、 Fmoc-L-苯丙氨酸N,N-二异丙基乙胺哌啶 作用下, 以 二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 2.5h, 以92%的产率得到(2S)-2-((2S)-2-((2S)-2-((3S)-3-amino-3-((3aR,6S,6aR)-6-(benzyloxy)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)propanamido)-3-phenylpropanamido)-3-methylbutanamido)propanoic acid
    参考文献:
    名称:
    Linear and cyclic glycopeptide as HIV protease inhibitors
    摘要:
    Novel linear and cyclic glycotetrapeptides were designed, synthesized and tested for inhibition of the wild type C-SA HIV-1 protease enzyme. The incorporation of beta-amino acid sugar to the linear and cyclic peptides resulted in a series of fifteen novel compounds. Linear glycopeptide 4a and cyclic glycopeptide 6a displayed significant activities against the HIV protease enzyme. The experimental results were compared with a computational approach using molecular docking. The sugar hydroxyl group at the C-3 position in linear (4a) as well as cyclic glycopeptide (6a), shows hydrogen bonding interaction with the enzymatic Asp25/Asp25' residues in docking studies. (C) 2012 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2012.11.018
点击查看最新优质反应信息

文献信息

  • Linear and cyclic glycopeptide as HIV protease inhibitors
    作者:Sachin A. Pawar、Amit M. Jabgunde、Glenn E.M. Maguire、Hendrik G. Kruger、Yasien Sayed、Mahmoud E.S. Soliman、Dilip D. Dhavale、Thavendran Govender
    DOI:10.1016/j.ejmech.2012.11.018
    日期:2013.2
    Novel linear and cyclic glycotetrapeptides were designed, synthesized and tested for inhibition of the wild type C-SA HIV-1 protease enzyme. The incorporation of beta-amino acid sugar to the linear and cyclic peptides resulted in a series of fifteen novel compounds. Linear glycopeptide 4a and cyclic glycopeptide 6a displayed significant activities against the HIV protease enzyme. The experimental results were compared with a computational approach using molecular docking. The sugar hydroxyl group at the C-3 position in linear (4a) as well as cyclic glycopeptide (6a), shows hydrogen bonding interaction with the enzymatic Asp25/Asp25' residues in docking studies. (C) 2012 Elsevier Masson SAS. All rights reserved.
查看更多

同类化合物

(-)-N-[(2S,3R)-3-氨基-2-羟基-4-苯基丁酰基]-L-亮氨酸甲酯 鹅肌肽硝酸盐 非诺贝特杂质C 霜霉灭 阿洛西克 阿沙克肽 阿拉泊韦 门冬氨酸缩合物 铬酸酯(1-),二[3-[(4,5-二氢-3-甲基-5-羰基-1-苯基-1H-吡唑-4-基)偶氮]-4-羟基-N-苯基苯磺酰氨酸根(2-)]-,钠 钠(6S,7S)-3-(乙酰氧基甲基)-8-氧代-7-[(1H-四唑-1-基乙酰基)氨基]-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸酯 金刚西林 醋酸胃酶抑素 酪蛋白 酪氨酰-脯氨酰-N-甲基苯丙氨酰-脯氨酰胺 透肽菌素A 连氮丝菌素 远霉素 达福普丁甲磺酸复合物 达帕托霉素 辛基[(3S,6S,9S,12S,15S,21S,24S,27R,33aS)-12,15-二[(2S)-丁烷-2-基]-24-(4-甲氧苄基)-2,8,11,14,20,27-六甲基-1,4,7,10,13,16,19,22,25,28-十羰基-3,6,21-三(丙烷-2-基)三十二氢吡啶并[1,2-d][1,4,7,10,13,16,19,22,25,28]氧杂九氮杂环三十碳十五烯并 谷胱甘肽磺酸酯 谷氨酰-天冬氨酸 表面活性肽 葫芦脲 水合物 葫芦[7]脲 葚孢霉酯I 荧光减除剂(OBA) 苯甲基3-氨基-3-脱氧-α-D-吡喃甘露糖苷盐酸 苯唑西林钠单水合物 苯乙胺,b-氟-a,b-二苯基- 苯乙胺,4-硝基-,共轭单酸(9CI) 苯丙氨酰-甘氨酰-缬氨酰-苄氧喹甲酯-丙氨酰-苯基丙氨酸甲酯 苯丙氨酰-甘氨酰-组氨酰-苄氧喹甲酯-丙氨酰-苯基丙氨酸甲酯 苯丙氨酰-beta-丙氨酸 苯丁抑制素盐酸盐 苄氧羰基-甘氨酰-肌氨酸 芴甲氧羰基-4-叔丁酯-L-天冬氨酸-(2-羟基-4-甲氧基)苄基-甘氨酸 艾默德斯 腐草霉素 脲-甲醛氨酸酯(1:1:1) 胃酶抑素 A 肠螯素铁 肌肽盐酸盐 肌氨酰-肌氨酸 聚普瑞锌杂质7 罗米地辛 缬氨霉素 绿僵菌素D 绿僵菌素C 绿僵菌素 B